A phase 1a/b study of RGT-61159, an oral MYB splicing modulator, in patients with advanced adenoid cystic carcinoma and colorectal cancer.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Alan Loh Ho, Enrique Sanz Garcia, Renata Ferrarotto, Paul Swiecicki, Alex Spira, John Frederick Hilton, Zujun Li, Cristina P. Rodriguez, Douglas Adkins, Hualin Simon Xi, Patricia Soulard, Travis Wager, Shiva Memari, Shireen Vali, Katherine LaRoque Jameson, Ivan Barrera, Jacqueline M. Walling, Glenn J. Hanna
Institutions: Memorial Sloan Kettering Cancer Center, University Health Network, University of Toronto, Princess Margaret Cancer Centre, The University of Texas MD Anderson Cancer Center, University of Michigan, U-M Rogel Cancer Center, Ottawa Hospital, NYU Langone Health, University of Washington, Washington University in St. Louis, Precision for Medicine (United States), Harvard University, Dana-Farber Cancer Institute
Language: English
Topic: RNA Research and Splicing
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7162549014